CBT
Undervalued by 9.4% based on the discounted cash flow analysis.
Market cap | $4.23 Billion |
---|---|
Enterprise Value | $4.38 Billion |
Dividend Yield | $1.72 (2.20541095012181%) |
Earnings per Share | $6.79 |
Beta | 1.03 |
Outstanding Shares | 54,300,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 10.01 |
---|---|
PEG | 11.64 |
Price to Sales | 1.01 |
Price to Book Ratio | -1.76 |
Enterprise Value to Revenue | 1.1 |
Enterprise Value to EBIT | 6.86 |
Enterprise Value to Net Income | 10 |
Total Debt to Enterprise | 0.03 |
Debt to Equity | 0.11 |
No data
No data